Research continues despite impact of funding deficit

Article

A lack of dependable funding is threatening to create a deficit of highly skilled scientists at a time when the U.S. could face a health care crisis brought on by devastating disorders, according to results of a recent study.

Clarksburg, MD-BrightFocus Foundation has released the results of a survey of more than 170 biomedical scientists that explores the most significant barriers to progress in ending eye and brain diseases.

The survey indicates that a lack of dependable funding is threatening to create a deficit of highly skilled scientists at a time when the nation could soon face a health care crisis brought on by devastating disorders such as Alzheimer’s, macular degeneration, and glaucoma.

“Nearly 20 million people in the U.S. are affected by Alzheimer’s disease, macular degeneration, or glaucoma. That number is climbing with an aging population, threatening our families, our health care, and our economy. Eradicating these diseases should be a much higher national priority,” said Stacy Haller, president and chief executive officer of BrightFocus Foundation, formerly named American Health Assistance Foundation.

For details of the survey and results, go to www.brightfocus.org/ResearcherSurvey2013.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.